This is a patient hypothesis, not medical advice. It is built on top of the strongest science I could find and graded honestly where the science runs out. The aim is not to talk anyone out of something that works - if D3 holds your seesaw level and gives you your life back, that is a genuine win. The aim is narrower: to understand how it is working, because that tells us whether vitamin D3 is the whole answer or only one weight on a balance.
A balance, not a switch
Picture a seesaw. Vitamin D3 sits on one side. Inflammation sits on the other.
While D3 holds its side down, the inflammatory side stays up - held above the line where a cluster attack fires. Take the weight off, and the inflammatory side drops. When it drops past that line, the attack begins. In this picture, D3 is not switching the disease off. It is leaning on a balance, keeping the other side from falling to the level where the pain lives.
That framing explains a lot of what people actually report. It explains why the regimen often has to be sustained indefinitely - remove the counterweight and the seesaw tips back. It explains why some people need ever-higher doses, and why a stubborn minority never respond at all: their side of the seesaw is simply carrying too much weight for D3 to lift. Those are the fingerprints of a suppressive intervention, not a causal one.
Which leads to the real question - the one D3 doesn't answer. Vitamin D can turn down the expression of inflammatory signals. But something is producing those signals in the central nervous system in the first place. What is putting the weight on the other side?
The counterweight: what vitamin D actually does
Here the biology is genuinely solid - with one honest caveat about where it has been shown. Active vitamin D (calcitriol) binds the vitamin D receptor, and that receptor sits on the brakes of the body's master inflammatory switch, the NF-κB pathway. Engage those brakes and the transcription of the classic pro-inflammatory messengers - TNF-α, IL-1β, IL-6 - goes down.12
This is well-replicated cell and molecular biology. One study traced a concrete lever: calcitriol lowered the importin that ferries NF-κB's active subunit into the nucleus, so less of the inflammatory signal ever reaches the genes it switches on.2 In living tissue, vitamin D3 supplementation reduced IL-6 and TNF-α alongside the phosphorylation steps of the same pathway.3
Every one of those experiments was done in general tissues - fat cells, immune cells, muscle - not in the trigeminal or hypothalamic tissue that actually generates a cluster attack. That vitamin D downregulates inflammatory mediators is established. That it does so in the specific circuit that fires cluster headache is an inference, not a measurement. It is reasonable. It is not proven.
So the counterweight is real. D3 can press down on the inflammatory side of the balance. The question is whether pressing down on inflammation is the same as addressing what cluster headache is.
The other side: what's putting weight on the balance
This is where cluster headache stops looking like a generic inflammatory condition and starts looking like something with a clock. The inflammation in cluster appears to be downstream of a timer, not random noise - and that changes everything about what D3 is and isn't doing.
The hypothalamus is the first mover. The defining feature of cluster headache is its timing - attacks at fixed clock hours, bouts at fixed seasons. In a landmark imaging study, attacks lit up the posterior hypothalamic grey matter, and that activation appeared only in the pain state, not between bouts - pointing to the hypothalamus as the primum movens.4 The hypothalamus houses the body's master circadian clock, which is exactly why cluster's "alarm-clock" punctuality and seasonal clustering make biological sense.5
CGRP is the engine of the attack. Once the threshold drops, the attack runs through the trigeminal-autonomic reflex, and the molecule doing the heavy lifting is CGRP. We know this is causal, not just correlated: infusing CGRP triggered cluster-like attacks in patients who were in an active bout - but not in those in remission.6 And blocking CGRP with galcanezumab cut attack frequency in a placebo-controlled trial of episodic cluster headache.7
The CGRP antibody worked for episodic cluster headache but failed its chronic-cluster trial.8 Even the closest thing we have to a targeted cluster drug only reaches part of the disease - another sign that the real driver sits upstream of any single mediator.
CGRP is far closer to the engine of cluster headache than the cytokines vitamin D suppresses. That is the crux of the seesaw argument: D3 leans on the inflammatory cytokine arm, while the attack is generated by a hypothalamic clock driving a CGRP-mediated reflex. Suppress the cytokines and you can raise the threshold - genuinely helpful - without ever touching the timer that keeps loading the other side.
But does D3 leave the timer untouched?
The seesaw rests on a clean division of labour: D3 works the inflammatory arm, the clock runs on its own. Recent molecular work smudges that line.
A 2025 review pulled together a quietly provocative case: vitamin D may not be purely an anti-inflammatory - it may also be a minor input to the clock itself. The vitamin D receptor has been shown to physically interact with CLOCK, the core driver of the clock's main feedback loop. And vitamin D's lesser-known hydroxyderivatives act as inverse agonists at RORα and RORγ and appear to engage the REV-ERBs - the exact nuclear receptors that switch clock genes like BMAL1 on and off.15 In cultured stem cells, simply adding active vitamin D was enough to synchronise the daily rhythm of BMAL1 and PER2, much the way a serum shock does.16 There is even an indirect channel: vitamin D helps drive the enzyme that converts serotonin into melatonin, the clock's own night-time messenger.15
Every one of these findings comes from skin cells, stem cells, immune cells, and metabolic tissue - or from molecular modelling. None of it was measured in the posterior hypothalamus, and none of it involved cluster headache. It is a reason to hold the "D3 never touches the timer" line a little more loosely - not evidence that vitamin D resets the clock in cluster. Even the review proposing these mechanisms calls them unvalidated.
So the honest update to the seesaw is narrow: D3 may not sit purely on the inflammatory pan - it might also rest a feather on the clock's side of the machinery. But a feather in a petri dish is not a hand on the hypothalamic clock of someone mid-bout. The practical reading is unchanged: get tested, expect a counterweight, keep looking upstream.
The seasonal clue: D3 standing in for sunlight?
Here is the most seductive part of the story - and the part to be most careful with. Cluster bouts cluster in time: seasonal predilection, nocturnal peaks, a strong circadian signature documented even in Arctic populations.9 Vitamin D rises and falls with sunlight on a seasonal cycle too. The overlap is tempting: maybe a falling vitamin D level is one of the seasonal signals the hypothalamus is misreading, and supplementing simply restores a cue the body lost.
It is a good hypothesis precisely because it has been tested - and so far the direct tests have not confirmed it. The one dedicated cluster cohort found patients were vitamin D deficient, but no more deficient than migraine patients or controls; the deficiency tracked the population and season, not the diagnosis.10 Two separate studies looking for vitamin D receptor gene variants in cluster patients came back largely negative.1112
The seasonal parallel is a correlation-shaped hypothesis, not a demonstrated mechanism - and seasonal cluster patterns are also explained by photoperiod and melatonin signalling that have nothing to do with vitamin D. The clock is real. That vitamin D is the hand on it is unproven.
The honest ledger: what we actually know
The hardest discipline in this whole subject is separating solid cluster-headache science from the promising-but-unproven vitamin D story. Every claim below is graded by the strength of its evidence.
What the seesaw predicts
A good hypothesis is falsifiable. If D3 is a counterweight rather than a cure, these patterns should follow - and they're exactly what people with cluster headache describe.
It must be sustained
Remove the weight and the balance tips back. A counterweight has to stay on the seesaw; a cure would not. Most people find they cannot stop.Some won't respond
When the hypothalamic / CGRP drive is heavy enough, no achievable dose of D3 can lift the other side past threshold. Non-responders are predicted, not anomalous.Cofactors prop, not cure
Magnesium, K2, omega-3 mostly support the same anti-inflammatory machinery (and D3's own metabolism). They reinforce the counterweight - they don't remove the load.Getting pain-free is not the same as the disease being gone. A balance held is still a balance under load.
None of this is a reason to stop something that works. The point is narrower and, I think, important: understanding D3 as a counterweight tells us the real target is still upstream - in the clock and the circuit that keep loading the other side. That is where a true solution, the thing that takes the weight off entirely, would have to act.